Jan 13 (Reuters) - Eli Lilly ( LLY ) has asked the U.S.
government to pause the new law that allows Medicare to
negotiate prices for its costliest prescription drugs, Bloomberg
News reported on Monday, citing Lilly Chief Executive Dave
Ricks.